STIMATE
gene geneOn this page
Also known as MGC52022
Summary
STIMATE (STIM activating enhancer, HGNC:30526) is a protein-coding gene on chromosome 3p21.1, encoding Store-operated calcium entry regulator STIMATE (Q86TL2). Acts as a regulator of store-operated Ca(2+) entry (SOCE) at junctional sites that connect the endoplasmic reticulum (ER) and plasma membrane (PM), called ER-plasma membrane (ER-PM) junction or cortical ER.
Enables calcium channel regulator activity. Involved in activation of store-operated calcium channel activity and store-operated calcium entry. Located in cortical endoplasmic reticulum; endoplasmic reticulum membrane; and endoplasmic reticulum-plasma membrane contact site.
Source: NCBI Gene 375346 — RefSeq curated summary.
At a glance
- GWAS associations: 23
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_198563
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30526 |
| Approved symbol | STIMATE |
| Name | STIM activating enhancer |
| Location | 3p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC52022 |
| Ensembl gene | ENSG00000213533 |
| Ensembl biotype | protein_coding |
| OMIM | 617189 |
| Entrez | 375346 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000355083, ENST00000464769, ENST00000467979, ENST00000477591, ENST00000482155, ENST00000485356, ENST00000902083, ENST00000924009, ENST00000963054
RefSeq mRNA: 1 — MANE Select: NM_198563
NM_198563
CCDS: CCDS2866
Canonical transcript exons
ENST00000355083 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001498283 | 52897291 | 52897548 |
| ENSE00001879972 | 52836733 | 52840610 |
| ENSE00003496987 | 52849792 | 52849913 |
| ENSE00003524455 | 52843721 | 52843798 |
| ENSE00003572442 | 52855396 | 52855444 |
| ENSE00003587573 | 52852603 | 52852698 |
| ENSE00003617039 | 52842811 | 52842960 |
| ENSE00003620815 | 52844829 | 52844941 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 92.23.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9484 / max 28.5508, expressed in 431 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 42489 | 14.1058 | 1796 |
| 42488 | 0.8959 | 401 |
| 42486 | 0.0292 | 16 |
| 42485 | 0.0232 | 7 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 92.23 | gold quality |
| liver | UBERON:0002107 | 90.39 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 89.37 | gold quality |
| right uterine tube | UBERON:0001302 | 88.98 | gold quality |
| popliteal artery | UBERON:0002250 | 88.55 | gold quality |
| tibial artery | UBERON:0007610 | 88.54 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 87.80 | gold quality |
| muscle tissue | UBERON:0002385 | 87.51 | gold quality |
| right coronary artery | UBERON:0001625 | 87.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 87.07 | gold quality |
| fallopian tube | UBERON:0003889 | 87.07 | gold quality |
| ascending aorta | UBERON:0001496 | 87.04 | gold quality |
| bone marrow | UBERON:0002371 | 86.81 | gold quality |
| bone marrow cell | CL:0002092 | 86.72 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 86.64 | gold quality |
| left coronary artery | UBERON:0001626 | 86.57 | gold quality |
| blood | UBERON:0000178 | 86.22 | gold quality |
| muscle of leg | UBERON:0001383 | 85.63 | gold quality |
| stromal cell of endometrium | CL:0002255 | 85.35 | gold quality |
| monocyte | CL:0000576 | 85.11 | gold quality |
| leukocyte | CL:0000738 | 84.95 | gold quality |
| mucosa of stomach | UBERON:0001199 | 84.91 | gold quality |
| sural nerve | UBERON:0015488 | 84.61 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.48 | gold quality |
| urinary bladder | UBERON:0001255 | 84.39 | gold quality |
| granulocyte | CL:0000094 | 84.10 | gold quality |
| tonsil | UBERON:0002372 | 83.50 | gold quality |
| body of pancreas | UBERON:0001150 | 83.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.79 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.74 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-100618 | yes | 2258.68 |
| E-ANND-3 | no | 1.85 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
134 targeting STIMATE, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
Literature-anchored findings (GeneRIF, showing 2)
- Data show that transmembrane protein 110 STIMATE is an endoplasmic reticulum (ER)-resident protein that co-localizes with membrane protein STIM1. (PMID:26322679)
- Research on calcium signaling has centered on STIM1, ORAI1, and proteins that modulate their function. TMEM110 regulates the maintenance of ER-plasma membrane junctions and the short-term remodeling of junctions during store-dependent calcium signaling. (PMID:26644574)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | stimate | ENSDARG00000013694 |
| mus_musculus | Stimate | ENSMUSG00000006526 |
| rattus_norvegicus | Stimate | ENSRNOG00000017051 |
Paralogs (1): MUSTN1 (ENSG00000272573)
Protein
Protein identifiers
Store-operated calcium entry regulator STIMATE — Q86TL2 (reviewed: Q86TL2)
Alternative names: STIM-activating enhancer encoded by TMEM110, Transmembrane protein 110
All UniProt accessions (4): F8WDI5, H7C503, H7C551, Q86TL2
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a regulator of store-operated Ca(2+) entry (SOCE) at junctional sites that connect the endoplasmic reticulum (ER) and plasma membrane (PM), called ER-plasma membrane (ER-PM) junction or cortical ER. SOCE is a Ca(2+) influx following depletion of intracellular Ca(2+) stores. Acts by interacting with STIM1, promoting STIM1 conformational switch. Involved in STIM1 relocalization to ER-PM junctions. Contributes to the maintenance and reorganization of store-dependent ER-PM junctions.
Subunit / interactions. Homooligomer. Interacts with STIM1.
Subcellular location. Endoplasmic reticulum membrane.
Tissue specificity. Widely expressed.
Domain organisation. The GXXXG motif may mediate oligomerization. The C-terminus is necessary for its localization at ER-plasma membrane (ER-PM) junctions as well as for the store-dependent rearrangement of ER-PM junctions.
Similarity. Belongs to the STIMATE family.
RefSeq proteins (1): NP_940965* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR022127 | STIMATE/YPL162C | Family |
Pfam: PF12400
UniProt features (13 total): transmembrane region 5, region of interest 3, topological domain 2, chain 1, short sequence motif 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86TL2-F1 | 69.62 | 0.21 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 241–246 | induces relocalization to cell membrane. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 146 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOBP_POSITIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, AP4_01, GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT
GO Biological Process (2): store-operated calcium entry (GO:0002115), activation of store-operated calcium channel activity (GO:0032237)
GO Molecular Function (2): calcium channel regulator activity (GO:0005246), protein binding (GO:0005515)
GO Cellular Component (5): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), cortical endoplasmic reticulum (GO:0032541), endoplasmic reticulum-plasma membrane contact site (GO:0140268), endoplasmic reticulum (GO:0005783)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| calcium ion transport | 1 |
| positive regulation of store-operated calcium channel activity | 1 |
| calcium channel activity | 1 |
| ion channel regulator activity | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| cell cortex | 1 |
| endoplasmic reticulum tubular network | 1 |
| organelle membrane contact site | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
924 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| STIMATE | SARAF | Q96BY9 | 781 |
| STIMATE | ORAI1 | Q96D31 | 702 |
| STIMATE | CRACR2A | Q9BSW2 | 698 |
| STIMATE | STIM1 | Q13586 | 669 |
| STIMATE | ESYT1 | Q9BSJ8 | 594 |
| STIMATE | ESYT3 | A0FGR9 | 581 |
| STIMATE | SLC35G1 | Q2M3R5 | 568 |
| STIMATE | NT5DC2 | Q9H857 | 510 |
| STIMATE | JPH4 | Q96JJ6 | 506 |
| STIMATE | ASPH | Q12797 | 480 |
| STIMATE | STIM2 | Q9P246 | 464 |
| STIMATE | NAPA | P54920 | 452 |
| STIMATE | NEK4 | P51957 | 421 |
| STIMATE | MUSTN1 | Q8IVN3 | 420 |
| STIMATE | OSBPL5 | Q9H0X9 | 403 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STIMATE | CCR4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CFTR | STIMATE | psi-mi:“MI:0915”(physical association) | 0.370 |
| GPR151 | TSPAN15 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): TMEM110 (Two-hybrid), TMEM110 (Affinity Capture-RNA), TMEM110 (Affinity Capture-MS), TMEM110 (PCA), TMEM110 (Cross-Linking-MS (XL-MS)), TMEM110 (Proximity Label-MS)
ESM2 similar proteins: A2VDL9, A9UY97, F4JY11, G4YM00, G4Z2L3, O17204, O42579, P15920, P16393, P20715, P30628, P36142, P54960, P70549, P93766, Q09906, Q18071, Q1RMW2, Q29BL9, Q2U0S9, Q3UF25, Q3UFJ6, Q4QQS1, Q54PI4, Q54WM0, Q5BPZ5, Q5FWM8, Q5RBL0, Q5XIT3, Q5Z413, Q61086, Q651J5, Q657S5, Q6P6G5, Q6VVA6, Q6ZMB5, Q7TSW6, Q86TL2, Q8BG09, Q8MRQ4
Diamond homologs: Q3UF25, Q7TSW6, Q86TL2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1911 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:52840520:T:TA | donor_gain | 1.0000 |
| 3:52840610:TC:T | acceptor_loss | 1.0000 |
| 3:52840611:C:CA | acceptor_loss | 1.0000 |
| 3:52840611:C:CC | acceptor_gain | 1.0000 |
| 3:52842805:CCCTA:C | donor_loss | 1.0000 |
| 3:52842806:CCTAC:C | donor_loss | 1.0000 |
| 3:52842807:CTA:C | donor_loss | 1.0000 |
| 3:52842807:CTACC:C | donor_loss | 1.0000 |
| 3:52842808:TACCT:T | donor_loss | 1.0000 |
| 3:52842809:A:T | donor_loss | 1.0000 |
| 3:52842810:C:A | donor_loss | 1.0000 |
| 3:52842820:AGACT:A | donor_gain | 1.0000 |
| 3:52842956:AAAGC:A | acceptor_gain | 1.0000 |
| 3:52842957:AAGC:A | acceptor_gain | 1.0000 |
| 3:52842958:AGC:A | acceptor_gain | 1.0000 |
| 3:52842959:GC:G | acceptor_gain | 1.0000 |
| 3:52842960:CC:C | acceptor_gain | 1.0000 |
| 3:52842960:CCTGT:C | acceptor_loss | 1.0000 |
| 3:52842961:C:A | acceptor_loss | 1.0000 |
| 3:52842961:C:CC | acceptor_gain | 1.0000 |
| 3:52842962:T:A | acceptor_loss | 1.0000 |
| 3:52843715:A:AC | donor_gain | 1.0000 |
| 3:52843716:C:CC | donor_gain | 1.0000 |
| 3:52843719:A:AC | donor_gain | 1.0000 |
| 3:52843720:C:CC | donor_gain | 1.0000 |
| 3:52843720:CG:C | donor_gain | 1.0000 |
| 3:52843796:CACCT:C | acceptor_loss | 1.0000 |
| 3:52843797:ACCT:A | acceptor_loss | 1.0000 |
| 3:52843798:CCTGT:C | acceptor_loss | 1.0000 |
| 3:52843799:C:CA | acceptor_loss | 1.0000 |
AlphaMissense
1926 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:52842938:T:A | D214V | 1.000 |
| 3:52842938:T:G | D214A | 1.000 |
| 3:52843734:G:T | P202H | 1.000 |
| 3:52852680:T:A | K76N | 1.000 |
| 3:52852680:T:G | K76N | 1.000 |
| 3:52855440:T:A | K55N | 1.000 |
| 3:52855440:T:G | K55N | 1.000 |
| 3:52842937:G:C | D214E | 0.999 |
| 3:52842937:G:T | D214E | 0.999 |
| 3:52842938:T:C | D214G | 0.999 |
| 3:52842939:C:A | D214Y | 0.999 |
| 3:52842939:C:G | D214H | 0.999 |
| 3:52842948:A:G | W211R | 0.999 |
| 3:52842948:A:T | W211R | 0.999 |
| 3:52843721:G:C | N206K | 0.999 |
| 3:52843721:G:T | N206K | 0.999 |
| 3:52843734:G:C | P202R | 0.999 |
| 3:52843735:G:A | P202S | 0.999 |
| 3:52843735:G:T | P202T | 0.999 |
| 3:52843737:A:T | V201D | 0.999 |
| 3:52843743:A:G | L199P | 0.999 |
| 3:52844918:A:G | W151R | 0.999 |
| 3:52844918:A:T | W151R | 0.999 |
| 3:52849795:A:G | Y142H | 0.999 |
| 3:52849800:C:A | G140V | 0.999 |
| 3:52849800:C:T | G140D | 0.999 |
| 3:52849878:C:T | G114D | 0.999 |
| 3:52849879:C:G | G114R | 0.999 |
| 3:52849890:T:A | D110V | 0.999 |
| 3:52849890:T:G | D110A | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000004747 (3:52842960 C>A,G), RS1000017797 (3:52851605 C>A), RS1000030087 (3:52840397 G>A), RS1000117991 (3:52846084 C>T), RS1000142464 (3:52891788 T>A,C), RS1000146688 (3:52881875 G>A), RS1000185018 (3:52875971 T>A,C,G), RS1000219037 (3:52880739 C>T), RS1000252568 (3:52846315 G>A), RS1000257897 (3:52885768 T>C,G), RS1000268134 (3:52897720 T>C,G), RS1000291132 (3:52846700 A>G), RS1000351332 (3:52873442 C>G), RS1000363530 (3:52891472 A>T), RS1000372248 (3:52869780 T>C)
Disease associations
OMIM: gene MIM:617189 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
23 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001241_15 | Bipolar disorder | 2.000000e-06 |
| GCST001535_11 | Immune reponse to smallpox (secreted IL-2) | 5.000000e-07 |
| GCST002149_14 | Schizophrenia | 1.000000e-08 |
| GCST002539_48 | Schizophrenia | 4.000000e-11 |
| GCST004125_5 | Type 2 diabetes (age of onset) | 8.000000e-06 |
| GCST004521_123 | Autism spectrum disorder or schizophrenia | 3.000000e-12 |
| GCST004521_203 | Autism spectrum disorder or schizophrenia | 4.000000e-08 |
| GCST004521_259 | Autism spectrum disorder or schizophrenia | 6.000000e-09 |
| GCST006269_1034 | General cognitive ability | 2.000000e-08 |
| GCST006269_1115 | General cognitive ability | 4.000000e-10 |
| GCST006803_55 | Schizophrenia | 1.000000e-11 |
| GCST008103_3 | Bipolar disorder | 7.000000e-11 |
| GCST008810_57 | Smoking initiation (ever regular vs never regular) | 8.000000e-11 |
| GCST010169_2 | Midgestational total 25-hydroxyvitamin D levels (fetal genetic effect) | 2.000000e-06 |
| GCST010988_144 | Adult body size | 3.000000e-13 |
| GCST011122_44 | Walking pace | 3.000000e-10 |
| GCST012228_64 | Waist-hip index | 4.000000e-08 |
| GCST90002391_14 | Mean corpuscular hemoglobin concentration | 2.000000e-09 |
| GCST90020024_1212 | A body shape index | 2.000000e-15 |
| GCST90020024_1214 | A body shape index | 1.000000e-14 |
| GCST90020025_1347 | Waist-to-hip ratio adjusted for BMI | 1.000000e-13 |
| GCST90020027_145 | Waist-hip index | 1.000000e-13 |
| GCST90020029_1201 | Waist circumference adjusted for body mass index | 5.000000e-15 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004645 | response to vaccine |
| EFO:0004873 | cytokine measurement |
| EFO:0004337 | intelligence |
| EFO:0005670 | smoking initiation |
| EFO:0007959 | fetal genotype effect measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| Aflatoxin B1 | increases methylation | 2 |
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | increases expression, affects cotreatment, increases abundance | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Arsenic | increases abundance, increases expression, affects cotreatment | 1 |
| Carbamazepine | affects expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_E0Q9 | Ubigene HeLa STIMATE KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.